The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072).
 
Derek Alderson
No Relationships to Disclose
 
Ruth E Langley
No Relationships to Disclose
 
Matthew Guy Nankivell
No Relationships to Disclose
 
Jane M. Blazeby
No Relationships to Disclose
 
Michael Griffin
No Relationships to Disclose
 
Adrian Crellin
No Relationships to Disclose
 
Heike I. Grabsch
Honoraria - AstraZeneca
 
Alicia Frances Clare Okines
No Relationships to Disclose
 
Cindy Goldstein
No Relationships to Disclose
 
Stephen Falk
Consulting or Advisory Role - Amgen; Celgene; Merck; Sanofi
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Celgene
 
Joyce Thompson
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
 
Richard Krysztopik
No Relationships to Disclose
 
Fareeda Y. Coxon
No Relationships to Disclose
 
Susan Pritchard
No Relationships to Disclose
 
Rupert Langer
No Relationships to Disclose
 
Sally Patricia Stenning
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)